Achievement
투세이프 인증과 관련된 연구성과에 대해 알려드립니다.
국외
Obstet Gynecol Sci.
Non-compliance with pregnancy prevention recommendations for isotretin…
2021
SCOPUS
Eun Jeong Choi, MD, Jung Yeol Han, MD, PhD
페이지 정보
본문
[Non-compliance with pregnancy prevention recommendations for isotretinoin in Korea between 2019-2020]
Objective
Isotretinoin is commonly prescribed worldwide despite its notorious teratogenicity. A risk management program (RMP) was introduced in Korea to prevent isotretinoin use during pregnancy. Here, we evaluate the compliance of Korean women with the recommendations of the RMP.
Methods
This prospective cohort study was conducted between April 2019 and June 2020. Thirty-six and 82 patients received the prescription before and after the introduction of RMP, respectively.
Results
There was a significant difference in the total number of days for which isotretinoin was prescribed before and after the RMP was introduced (68.8±100.9 and 28.0±26.1 days, respectively). However, 1.43% (120/8,394) of the total patients contacted by the teratology information services were exposed to isotretinoin on an average.
Conclusion
The proportion of patients exposed to isotretinoin did not change, and there was no significant change in
compliance, with the implementation of the RMP during the study period. Further studies are needed to evaluate the effectiveness of the RMP in the long term.
